| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
55,534 |
49,202 |
$1.81M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,534 |
19,027 |
$907K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,130 |
7,113 |
$292K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,609 |
5,864 |
$283K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,717 |
2,605 |
$137K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,560 |
3,099 |
$81K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,639 |
7,639 |
$68K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,619 |
1,543 |
$60K |
| H1000 |
Prenatal care, at-risk assessment |
244 |
199 |
$23K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
352 |
332 |
$21K |
| 59025 |
Fetal non-stress test |
1,045 |
664 |
$19K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
331 |
301 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
660 |
627 |
$15K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,355 |
2,201 |
$14K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
154 |
136 |
$11K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
230 |
229 |
$11K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
248 |
212 |
$10K |
| 51798 |
|
1,066 |
1,010 |
$8K |
| 20610 |
|
240 |
206 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
113 |
97 |
$7K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
47 |
44 |
$6K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
561 |
541 |
$6K |
| 69210 |
|
402 |
374 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
138 |
130 |
$5K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
337 |
169 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
100 |
97 |
$4K |
| 92557 |
|
108 |
106 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
256 |
208 |
$3K |
| 0002A |
|
68 |
67 |
$3K |
| 0001A |
|
96 |
87 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
61 |
54 |
$2K |
| 92567 |
|
227 |
224 |
$2K |
| 52000 |
|
65 |
63 |
$2K |
| 76830 |
Ultrasound, transvaginal |
28 |
26 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
129 |
123 |
$2K |
| 90686 |
|
1,027 |
992 |
$2K |
| 99220 |
|
42 |
36 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
24 |
24 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
43 |
41 |
$1K |
| 90671 |
|
158 |
145 |
$1K |
| 90670 |
|
1,180 |
1,028 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
316 |
298 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
45 |
40 |
$1K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
13 |
13 |
$1K |
| 99217 |
|
52 |
51 |
$982.24 |
| 99460 |
|
12 |
12 |
$941.64 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
73 |
39 |
$853.26 |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
13 |
12 |
$789.81 |
| 95251 |
|
173 |
165 |
$784.83 |
| 99215 |
Prolong outpt/office vis |
17 |
17 |
$773.60 |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
29 |
24 |
$771.71 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$438.24 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
13 |
$428.26 |
| 81003 |
|
329 |
311 |
$380.17 |
| 99443 |
|
12 |
12 |
$364.23 |
| 99305 |
|
25 |
25 |
$320.58 |
| 99442 |
|
13 |
13 |
$266.22 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
22 |
13 |
$244.35 |
| 0031A |
|
12 |
12 |
$204.00 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$163.00 |
| 11721 |
|
12 |
12 |
$147.18 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
368 |
348 |
$145.46 |
| 87807 |
|
12 |
12 |
$111.29 |
| 85018 |
|
58 |
50 |
$102.67 |
| 96127 |
|
37 |
36 |
$92.73 |
| 87210 |
|
20 |
13 |
$78.64 |
| 99307 |
|
14 |
13 |
$54.33 |
| 90648 |
|
650 |
636 |
$29.52 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$16.64 |
| 90647 |
|
117 |
111 |
$10.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
23 |
12 |
$3.21 |
| 91307 |
|
19 |
18 |
$0.19 |
| 91300 |
|
214 |
193 |
$0.13 |
| 91303 |
|
12 |
12 |
$0.12 |
| 90697 |
|
69 |
67 |
$0.00 |
| 90680 |
|
402 |
381 |
$0.00 |
| 90723 |
|
387 |
381 |
$0.00 |
| 90661 |
|
27 |
26 |
$0.00 |
| 90633 |
|
37 |
33 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
12 |
12 |
$0.00 |
| 90707 |
|
24 |
16 |
$0.00 |